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Abstract.  The expression of NCAM (neural cell adhe- 
sion molecule) is precisely regulated in terms of cell 
type specificity and developmental control.  We 
searched for extracellular factors that may be involved 
in this regulation using N2A neuroblastoma and NIH 
3T3 fibroblastic cells.  Factors contained in FBS 
promoted a two- to threefold increase in NCAM pro- 
tein and mRNA abundance in both cell lines.  This in- 
crease in NCAM expression in high serum could be 
entirely attributed to enhanced levels of the NCAM- 
140 message.  Modulation of NCAM synthesis via an 
autocrine mechanism is suggested by the observation 
that medium conditioned by N2A cells stimulated 
NCAM mRNA expression by 3T3 and N2A cells. 
Among the pure factors tested, transforming growth 
factor-beta (TGFfl) was found to act as an inducer of 
NCAM expression in 3T3 but not in N2A cells. 3T3 
cells responded to exposure to TGF/$ with a two- to 
threefold increase in NCAM protein and mRNA.  Ex- 
posure of early-passage embryonic cells to TGFfl 
resulted in four- and twofold increases in NCAM pro- 
tein and mRNA abundance,  respectively, suggesting a 
role for TGFfl in modulating NCAM expression in the 
embryo. TGF~ seems to act by stimulating the tran- 
scriptional activity of the NCAM gene because it did 
not affect transcript  stability and stimulated transcrip- 
tion from a proximal promoter element of the NCAM 
gene. 
T 
HE neural  cell  adhesion  molecule (NCAM) t is  the 
name given to a group of closely related  cell surface 
glycoproteins that function as ligands in the formation 
of cell-cell contacts.  NCAM, together with the members of 
the cadherin family (Takeichi,  1988), belongs to the primary 
or general cell adhesion molecules that are expressed early 
in development and on a variety of cell types. These mole- 
cules are believed to play critical roles in specifying cell pat- 
terning,  movement, and differentiation  in the embryo and in 
maintaining  tissue integrity in the adult organism (Edelman, 
1985;  1988; Rutishauser  and Jessel, 1988; Takeichi,  1988; 
Thitry,  1989).  NCAM expression is precisely regulated in 
terms of tissue distribution and developmental  control. The 
total amounts of NCAM and the relative proportions of its 
isoforms, which arise from a single gene by differential pro- 
cessing of the pre-mRNA (Cunningham  et al., 1987; Barbas 
et al.,  1988; Santoni et al., ,1989), change during develop- 
ment and differentiation  (PoUerberg et al., 1985; Murray et 
al.,  1986). In the embryo, NCAM is expressed transiently 
on derivatives of all three germ layers, often in morphogenet- 
ically active  regions such as the notochord, placodes, so- 
mites, and the neural  crest (Thitry et al.,  1982; Crossin et 
al.,  1985; Balak et al.,  1987; Levi et al., 1987). The tissue 
1. Abbreviations gsedin thispaper: EGE epidermal growth factor; NCAM, 
neural cell adhesion molecule; NGE nerve growth factor; TGE transform- 
ing growth factor. 
distribution  of NCAM becomes more limited during further 
development.  In the perinatal period, it still includes  most, 
if not all,  neurones and glial cells and skeletal  and cardiac 
muscle fibers  (Langley  et al.,  1983;  Chuong  et al.,  1984; 
Rieger et al.,  1985; Covault  et al.,  1986;  Prediger et al., 
1988). NCAM persists on most neurons and astrocytes in the 
central  nervous system, and on neuronal  cell bodies, their 
unmyelinated axons and nonmyelinating Schwarm cells in the 
peripheral nervous system in the adult (Langley et al., 1983; 
Chuong et al.,  1984; Nieke and Schachner,  1985).  It can, 
however, be reinduced in the denervated muscle and at sites 
of nerve injury and repair (Covault et al., 1986; Daniloff et 
al.,  1986; Martini  and Schachner,  1988). 
The three main NCAM isoforms in the mouse, which we 
have called NCAM-180, -140, and -120 according to their ap- 
parent relative  molecular masses in SDS gels (Rutishanser 
and  Goridis,  1986),  are encoded by four size classes of 
mRNAs: transcripts  of 6.9 and 6.1 kb code for NCAM-180 
and -140, respectively; two smaller transcripts  of 4.8 and 2.7 
kb code for NCAM-120. These messages are generated from 
the single NCAM gene by a combination of alternative  splic- 
ing and the choice among one of three poly(A) addition sig- 
nals (Barbas et al., 1988). Their expression changes during 
development and differentiation as has been particularly well 
documented  during  muscle  development  (Covault  et  al., 
1986; Moore et al.,  1987). 
Despite a  wealth  of information  on the  expression  se- 
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very little as to how its expression is regulated. In particular, 
the extracellular signals involved in the control of NCAM 
levels in the embryo and its reinduction after nerve injury 
have remained unknown, the only growth or differentiation 
factor reported to influence NCAM expression being nerve 
growth factor (NGF) (Prentice et al.,  1987; Doherty et al., 
1988). 
We have used the N2A mouse neuroblastoma and the NIH 
3T3 fibroblastic cell lines to search for extracellular factors 
that might influence NCAM expression by these cells. N2A 
cells are known to express constitutively high amounts of 
NCAM which has been studied with respect to its protein 
and mRNA forms and its mobility at the cell surface (Poller- 
berg  et  al.,  1985;  1986;  Gennarini et  al.,  1986).  Most 
fibroblastic cells are NCAM negative. However, NCAM has 
been found on some fibroblasts from peripheral nerve and 
denervated muscle (Martini and Schachner,  1988;  Gatch- 
allan et al., 1989) and its expression in embryonic mesen- 
chyme (Crossin et al., 1985) suggests that it can be expressed 
on fibroblast precursors. In the course of  this study, we found 
that NCAM is indeed expressed in primary and secondary 
cultures of fibroblastic cells from the mouse embryo com- 
monly referred to as embryonic fibroblasts. 
In this study, we demonstrate that NCAM protein and 
mRNA levels are regulated in N2A and 3T3 cells by (a) fac- 
tor(s) contained in serum and in N2A cells in addition by an 
autocrine mechanism. When testing a variety of growth and 
differentiation factors, we found that transforming growth 
factor-beta (TGF/$) promoted a net increase in NCAM pro- 
tein and mRNA levels in fibroblasdc cells, not only in an es- 
tablished cell line, but also in early-passage embryo-derived 
cultures. These findings suggest that TGFB is involved in the 
regulation of NCAM expression in the embryo, possibly also 
at sites of nerve injury where NCAM has been found to be 
induced on fibroblastic cells (Nieke and Schachner,  1985; 
Gatchalian et al.,  1989). 
Materials and Methods 
Cell Culture 
The C1300 mouse neuroblastoma-derived N2A cell, the mouse L cell (sub- 
clone LM tk-) and the NIH 3T3 fibroblastic cell line were grown in DME 
containing 10% FBS (complete growth medium) at 37°C in an atmosphere 
of 7.5%  COz in air.  Identical results were obtained when newborn bovine 
serum was used in place of FBS. Routinely,  the cells were grown to 80% 
confluency before serum starvation or analysis of the effects of different 
agents. Serum-staiwed cultures were prepared by switching to DME with 
0.2% FBS for N2A and to DME without serum for 3T3 cells. In some ex- 
periments, DME/F12 (1:1) medium supplemented with 10 ~g/ml transferrin 
and 30 nM selenium was used. The following growth and differentiation fac- 
tors were added in the concentrations and for the time periods specified in 
the legends: TGF/~ (ultrapure TGF/~ from human platelets, Calbiochem- 
Behring Corp., La Jolla, CA), purified 131- and/3z- subtypes of TGF/3 from 
porcine platelets (British Biotechnology Ltd., Oxford, UK), human recom- 
binant PDGF  (G-enzyme Corp., Boston,  MA), epidermal growth factor 
(EGF) from mouse submaxillary glands, and basic fibroblast growth factor 
(bFGF) from bovine pituitary and nerve growth factor (NGF) (7S NGF 
from mouse submaxillary glands). EGF, bFGF, and NGF were purchased 
from Sigma Chemical Co. (St. Louis, MO) as well as retinoic acid, phorbol 
myristate acetate, and actinomycin D. 
Embryo-derived fibroblastic ceils were prepared from 16-d-old embryos 
of Swiss mice as described by Arnheiter and Staebeli (1983)  with slight 
modifications. After removal of head, limbs, and bowels, the trunks were 
minced and incubated in 0.125 % crude trypsin (Gibco Laboratories, Grand 
Island, NY) in PBS at 37°C. Every hour, the released single cells were col- 
lected, fresh trypsin was added and the incubation continued for a total of 
4 h. The cells were pooled, collected by centrifugation and allowed to ad- 
here to tissue culture plastic dishes for 1 h in DME with 10% FBS. After 
1 h, the nonadherent cells were discarded and the cultures grown in DME 
with 10% FBS. They were subculmred by trypsinization. First and second 
passage cells were used in all experiments. 
To test for cell viability and changes in cell number under different cul- 
ture conditions the MTT assay (Mosmann, 1983) as modified by Doberty 
et ai. (1988) was used. Dimethylthiazol-2-yl-2,5 diphenyltetrazolium bro- 
mide (MTT; Sigma Chemical Co.) was added at 0.5 mg/ml to cells in 96- 
weU-microtiter plates for 2 h at 37°C. After stopping the reaction with 0.08 N 
HC1 in isopropanul, color formation due to production of MTT formazin 
was measured at 540 nm with a  microelisa reader (Multiscan; Titertek, 
Flow Laboratories S.A., Puteaux, France). 
lmmunocheraical Detection and Quantij~cation of 
NCAM and 12 Protein 
For immune blot  analysis,  NP-40 extracts  were prepared and NCAM  pro- 
teins  revealed after  electrophoresis  and transfer  to nitrocellulose  by rabbit 
anti-NCAM antibodies and lzSI-protein  A as described (Gennarini et ai., 
1986). 
The NCAM and L1 antigen content of the cultures was determined by 
a dot blot assay. Cells were lysed in 0.1% deoxycholate, 20 mM Tris HC1 
pH 8.5, 20 mM NaCI,  1 mM MgCIz, 5 mM DTT,  0.1 mM PMSF. Serial 
dilutions of the cleared (12,000 g, 30 rain) lysates were spotted on nitrocel- 
lulose paper (0.2 inn pore size, Schleicher &  Schiill, Dnssel, FRO) with 
the help of  a dot blot apparatus. To block nonspecific  binding, the nitrocellu- 
lose sheets were incubated for 1 h at 37°C in PBS containing 5% deferred 
dry milk. Specific antibody appropriately diluted in the same solution was 
then added for 16-20 h at 4°C. The filters were washed four times in PBS 
containing 5 % dry milk and bound antibody revealed by incubation for 1 h 
at room temperature with protein A  (0.5  ×  106 cpm/ml) iodinated with 
[~251] to a specific activity of 20-30  x  106 cpm/~g. The radioactive spots 
were cut out and the radioactivity determined in a gamma counter. The 
amounts of antigen in the lysates were calculated from the linear region of 
the dilution curves and expressed in cpm per ~g protein contained in the 
undiluted extracts. 
The preparation and specificity of the rabbit anti-NCAM (anti-NCAM- 
120, -140, and -180) antiserum (C,  eanarini et at.,  1986)  and of the rabbit 
anti-L1 antiserum (Rathjen and Schachner, 1984; a kind gift of M. Schach- 
ner, ETH Ziirich) have been described. Rabbit antibodies specific for NCAM- 
180 were prepared against a bacterial fusion protein composed ofa genomic 
fragment encoding the NCAM-180-specific exon 0Barbas et at., 1988) cou- 
pled to/3-galactosidase, as will be described in detail elsewhere. In immune 
blots of brain extracts or of affinity-purified NCAM, this antiserum recog- 
nized only  an 180-kD band. As shown by inununofluorescence experiments, 
the  antibodies  did not  stain  NCAM-negative cells  and reacted  only with per- 
meabilized NCAM-180-expressing  cells  due to  the intracellular  localization 
of  the epitope (results  not shown). All rabbit  sera were used at  a 1/500 di- 
lution. 
Northern Blot Analysis and Quantification of mRNA 
Total RNA was extracted directly from the cell monolayer in culture flasks 
in 4 M guanidinium thiocyanate followed by phenol/chloroform extraction 
according to Chomczynski and Sacchi (1987).  RNA was quantified by mea- 
suring the OD at 260 rim.  For Northern blot analysis, samples containing 
10-15 #g of RNA were fractionated on 0.8 % formaldehyde-containing  aga- 
rose gels as previously described (Genuarini et at., 1986).  The RNA was 
transferred on Hybond-C (Amersham Chemical Co.) and hybridized with 
2-3  x  106 cpm/ml of the radioactive probe. Probe labelling and conditions 
for hybridization, washing and autoradiography were as described (C-enuar- 
iniet al.,  1986).  The NCAM eDNA probe used was the 5' part of clone 
DW3 (DW3LE; Barthels et ai., 1987); clone KI 3 (Moos et ai., 1988; a kind 
gift  of  R. Tacke, Centre d'Immunologie de Marseille-Luminy)  was used as 
a  probe to  reveal  the  LI mRNA.  Depending on the  size  markers used, differ- 
ent sizes have been assigned to the four size classes of NCAM mRNAs de- 
tected in the mouse. To arrive at a consistent nomenclature and in keeping 
with a previous publication (Santoni et al.,  1989),  we will call the tran- 
scripts according to their calculated sizes (minus the poly[A] tail) deduced 
from the eDNA sequence of the corresponding brain transcripts. In all 
Northern blots, RNA from mouse brain was run alongside and the comigrat- 
ing bands in the different cell types were assigned accordingly. 
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tured in high and low serum. N2A cells were cultured in 10 or 0.2 % 
FBS for 24 h before harvesting and lysis in 0.1% deoxycholate.  (A) 
Autoradiograph of dot blots containing serial  twofold dilutions  of 
N2A cell lysates developed  with rabbit anti-total NCAM (NCAM- 
180, -140,  and -120) serum (NCAM), NCAM-180-specific  rabbit se- 
rum (NCAM-180), and rabbit anti-L1 serum (L/). The dot blot was 
first incubated  with the relevant antiserum diluted  1:500 and bound 
antibody was revealed  with [~25I]protein A. The radioactive  spots 
were then cut out and counted. The total NCAM, NCAM-180 and 
L1 immunoreactivities  expressed  as counts per minute/microgram 
protein are given below. The dilution series developed with anti-L1 
serum started at a twofold higher protein concentration and was ex- 
posed four times longer. In each case, the counts from three to four 
dilutions  that fell within the linear range of the response were aver- 
aged. Very similar results were obtained in more than six indepen- 
dent  experiments.  No detectable  NCAM  immunoreactivity was 
found in extracts of L cells that do not express NCAM (not shown). 
(B) Northern blot done with total RNA extracted  from N2A cells 
and probed for NCAM, L1, and GAPDH mRNA. The cells, seeded 
at 0.5  ×  106 cells  per 25-cm  2 flask,  were grown for 48 h in 10% 
FBS, then switched to 0.2%  FBS and harvested 24 h later (0.2%), 
or after 24 h in 0.2%  FBS,  they were switched  back to complete 
growth medium for another 24 h (0.2/10%).  Cells  grown in 10% 
FBS for 48 h were taken as a control (10%). The sizes of  the NCAM- 
180- (6.9) and NCAM-140-  (6.1) specific bands are given in kilo- 
bases.  They comigrated precisely with the corresponding mRNA 
species from mouse brain, for which sizes of 6.9 and 6.1 kb (minus 
the poly[A] tail)  have been determined by sequence  analysis.  The 
fainter band of smaller size runs just ahead of the 28S rRNA and 
probably represents hybridizing material that is being pushed ahead 
by the large amounts of rRNA.  The  intensity  of the bands  was 
quantified  by densitometric scanning of the autoradiographs. The 
values  are given below the autoradiographs in arbitrary units. 
A cDNA coding for glyceraldehydephosphate  dehydrogenase (GAPDH) 
(Hanauer and Mandel,  1984;  a kind gift of J. L. Mandel, Laboratoire de 
Gtnttique Moltculaire des Eucaryotes, Strasbourg) was used as reference 
probe. The levels of GAPDH protein and mRNA are known not to change 
during the Go to G1 transition and not to be influenced by various growth 
factors including TGF/~ (Edwards et al., 1985;  1987).  The NCAM- and L1- 
specific bands in the atttoradiographs were quantified by scanning using a 
Vernon densitometer. Each blot was exposed for different times, and the 
values were taken from exposure times that fell in the linear range of the 
film and densitometer response. The crude values obtained for NCAM and 
L1 mRNA abundance were normalized by dividing them by the values ob- 
tained for GAPDH mRNA. 
In the actinomycin D chase experiments, NCAM mRNA levels were de- 
termined by a dot-blot procedure. 5/zg of total RNA were dissolved in 50 
#1 H20, 30/~120×  SSC (1×  SSC is 15 mM Na citrate, 0.15 M NaC1, pH 
7.0) and 20 #1 37% formaldehyde and denatured for 15 min at 60"C. Serial 
dilutions in 20 ×  SSC were dotted on Hybond-C. The blots were first hybrid- 
ized  with the  NCAM  probe  and,  after  total  dehybridization,  with  the 
GAPDH probe. After autoradiography, the intensity of  the spots was deter- 
mined by densitometric scanning. Mean values for different dilutions were 
determined by  regression analysis of the linear  portion of the dilution 
curves. 
Transfections and Determination of  Chloramphenicol 
Acetyltransferase Activity 
The recombinant plasmid used contains a 608-bp fragment (position -645 
to -37 relative to the start site of translation) from the 5' end of the mouse 
NCAM gene coupled to the chloramphenicol acetyltransferase (CAT) gene 
from pconaCAT (Kimura et ai.,  1986).  In a previous study (Hirsch et al., 
1990),  this fragment has been shown to contain the transcriptional start 
sites and to exert high promoter activity in NCAM-expressing cells. 
NIH  3T3  cells were plated at a  density of 5  x  105 cells per 250-ml 
flask. 20 h later, they were transfocted with 20/,tg plasmid DNA by the cal- 
cium phosphate coprecipitation method (Gorman, 1985). After 16 h, a 10 % 
DMSO shock was applied for 10 min. For each experiment, four sister cul- 
tures were transfected. After the DMSO shock, the cells from the four flasks 
were recovered by trypsinization, pooled, and redistributed into four flasks 
at a ratio of 1:1:3:3. The two sparser cultures were maintained in DME with 
10% FBS throughout; in the two denser ones, the serum concentration was 
lowered to 1% 6 h and to 0.2%  16 h after replating. 6 h after subculturing, 
one of each of the high- and low-serum cultures received 200 pM TGF/~ 
All culaLres were harvested between 40 and 48 h after subeulturing.  Approxi- 
mately the same numbers of  cells were recovered from high- and low-serum 
cultures in the presence or absence of TGF~ CAT activity was determined 
on aliquots of cell lysates containing equal amounts of protein according to 
Gorman (1985).  The percent conversion of [14C]chloramphenicol into its 
acetylated derivatives was determined by cutting out the corresponding spots 
from the thin layer plates followed by scintillation counting. 
Results 
Modulation of  NCAM Protein and mRNA Levels in 
N2A Cells by Serum and Autocrine Factors 
The N2A mouse neuroblastoma cell line was chosen as an 
example of a neural cell line to analyze the effects of culture 
conditions and extracellular  factors on NCAM expression. 
A  quantitative dot-blot immunoassay, an example of which 
is shown in Fig. 1 A, was used to measure the NCAM protein 
content. N2A cells expressed around two- to threefold higher 
amounts of NCAM protein per/zg total protein when grown 
in 10 % (complete growth medium) than in 0.2 % (low-serum 
medium)  FBS  (Fig.  1  A)  or  in  serum-free  medium  sup- 
plemented with selenium and transferrin (synthetic medium) 
(not shown). By contrast, the levels of the L1 adhesion mole- 
cule (Rathjen and Schachner, 1984; Moos et al.,  1988) were 
higher in low-serum than in complete (Fig.  1) or in synthetic 
medium (not shown). Hence, serum starvation caused oppo- 
site changes in the levels of two structurally related (Moos 
et al.,  1988) adhesive proteins.  In contrast to the decrease 
in total NCAM protein abundance in low serum, NCAM-180 
levels measured with a  specific antibody were not modified 
in the presence of low serum (Fig.  1 A), showing that an in- 
crease in the relative proportions of NCAM-180 to NCAM- 
140 expressed by N2A cells is induced by serum starvation 
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Figure 2. Effect of  cell density on NCAM levels in N2A cells. N2A 
cells  were plated  at various  cell densities  (0.1-1.5  x  106 ceils per 
25-cm  2 culture dish)  in 10 or 0.2%  serum.  After 48 h, the cells 
were harvested and counted with a  hemocytometer. Cell lysates 
(25-50 #g protein)  were dot blotted and assayed  for total NCAM 
immunoreactivity as described in the legend to Figure 1. The re- 
suits expressed as counts per minute/microgram protein are plotted 
as a function of cell density at the time of harvest. 
NCAM Expression by NIH 3T3 Cells 
Most normal fibroblasts do not express NCAM, but in the 
embryo,  NCAM  is  present  in  undifferentiated  mesoderm 
(Crossin  et  al.,  1985)  which  should  include  fibroblast 
precursors.  We chose the NIH 3"1"3 cell line as an example 
of embryo-derived,  fibroblastic cells.  AS shown in Fig.  4, 
3T3 cells expressed readily detectable levels of NCAM-140 
but not of NCAM-180; a faint band in the NCAM-120 region 
became visible after prolonged exposure.  The NCAM-140 
band from these cells consistently run with a slightly lower 
mobility than the corresponding isoform from N2A cultures 
or whole mouse brain. This slight mobility shift may be due 
to glycosylation differences or to the presence of a short ad- 
ditional stretch of amino acids as has been reported for mus- 
cle NCAM (Dickson et al.,  1987). The material analyzed on 
lanes 2  and 3  was derived from identical  numbers of cells 
showing that on a per cell basis, 3T3 cells contained approxi- 
alone and does not require the presence of additional factors 
such as DMSO and laminin (Pollerberg et al.,  1985; 1986). 
Similar changes occurred in the levels of the corresponding 
mRNA species.  As shown in Fig.  1 B, serum starvation re- 
suited in an over twofold decrease in the level of the 6.1-kb 
message  that codes  for NCAM-140  (Barbas  et  al.,  1988), 
whereas the 6.9-kb species, which is specific for NCAM-180, 
was not affected.  The effect was reversible since the values 
were restored to control levels when serum was added back 
to the cultures.  As already observed at the protein level, L1 
mRNA expression  increased in low-serum conditions.  Re- 
hybridization with a eDNA probe for GAPDH, a key enzyme 
of the glycolytic pathway, which is not affected by the Go to 
G, transition of the cell cycle (Edwards et al.,  1985), showed 
that equivalent amounts of total mRNA has been applied to 
the  different  lanes.  Serum  factors appear  thus  to  regulate 
NCAM and L1 expression at the level of synthesis, process- 
ing or stability  of the corresponding mRNAS. 
In addition to the serum content of the medium, cell den- 
sity had a pronounced effect on NCAM protein levels of N2A 
cells grown in 10%  serum with a  steep increase between  1 
and 2  X  106 cells per dish (Fig.  2).  Serum starvation still 
caused a clear down-regulation of NCAM levels at identical 
cell densities, making it unlikely that an increase in cell den- 
sity was in fact responsible for the observed effect of serum 
factors.  The cell-density dependence of NCAM expression 
suggested to us that an autocrine factor might be involved in 
the regulation of NCAM expression by N2A cells.  Indeed, 
medium conditioned by N2A cells promoted a threefold in- 
crease in the level of total NCAM transcripts over that mea- 
sured  in  N2A  cultures  exposed  to  3T3  cell-conditioned 
medium (Fig.  3, lanes a  and b). There was no difference in 
NCAM  transcript  expression  between  cultures  grown  in 
fresh or 3T3 cell-conditioned medium (results  not shown). 
In contrast to serum, conditioned medium affected both the 
6.9- and the 6.1-kb species; therefore, the putative autocrine 
and the serum factors must be different molecules. 
Figure 3. Effect of N2A-cell Conditioned medium on NCAM mRNA 
expression  by N2A and 3T3 cells.  A Northern blot probed with a 
mixture of NCAM and GAPDH cDNAs is shown.  Lanes a and b, 
N2A cells, lanes c and d, 3T3 cells; lanes a and c, cultures exposed 
to 3T3-conditioned  medium;  lanes  b  and d, cultures  exposed  to 
N2A cell-conditioned medium. The sizes of the bands are given in 
kilobases.  In this experiment,  small amounts of the 4.8- and 2.7-kb 
transcripts  were also revealed.  The band that runs just in front of 
the 4.8-kb species is an artifact due to hybridizing material  pushed 
ahead by the 28S rRNA. The smaller-size  bands represent  at most 
20 % of the total hybridizing material  and were not included in the 
quantitative  analysis of the conditioned medium effect. Fresh com- 
plete growth medium was added to near confluent cultures of N2A 
or 3T3 cells. The medium was harvested 24 h later, cleaned by cen- 
trifugation,  and stored at  -20°C.  N2A and 3T3 cells (5  x  1@ 
ceils per 25-cm  2 dish)  were grown in complete medium for 24 h, 
then  medium consisting  of 50%  conditioned medium  and  50% 
fresh complete growth medium was added. After 24 h in the pres- 
ence of conditioned medium,  the ceils were harvested  and pro- 
cessed  for RNA analysis. 
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passage embryo ceils in the presence and absence of TGF/$. Ex- 
tracts of postnatal-d 20 mouse brain (lane 1), of N2A cells grown 
in complete  medium (lane 2),  of 3T3 ceils  grown in complete 
medium in the absence (lane 3) or presence (lane 4) of 200 pM 
TGF/~ and of first passage ceils from 16-d-old embryos grown in 
complete medium in the absence (lane 5) and presence (lane 6) of 
200 pM TGF/3  were fractionated by SDS-PAGE  and transferred to 
nitrocellulose.  NCAM-immunoreactive bands  were  revealed by 
rabbit  anti-NCAM  serum  followed by  p251]protein A.  In  lanes 
2-4, material from 4  x  105 cells was analyzed, in lanes 5 and 6, 
2  x  105 cell equivalents were loaded on each lane. TGF/3 treat- 
ment was for 24 and 48 h for 3T3 and embryo cells, respectively. 
mately one third of the NCAM protein expressed by N2A 
ceils. Northern blot analysis showed that 3T3 ceils expressed 
nearly exclusively the 6.1-kb mRNA species as could be an- 
ticipated from the immune blot data (see Fig.  8). 
The levels of NCAM protein and mRNA in 3T3 cells were 
also affected by serum factors: serum-starved 3T3 cells con- 
tained around two- to threefold less NCAM protein per #g 
of total protein and two- to threefold lower levels of NCAM 
transcripts than cultures grown in 10% FBS (see Figs. 6, A 
and B and 8).  By contrast, the pronounced dependence of 
NCAM expression on cell density observed in N2A cells was 
not seen in 3T3 cultures. In fact, the relative abundance of 
NCAM protein and mRNA was very similar whether cells 
seeded at the same density were grown for 1, 2, or 3 d  in 
10% serum (data not shown). This result fits in with the fact 
that we could not detect an autocrine effect on NCAM ex- 
pression  mediated  by  3T3  cell-conditioned medium.  3T3 
cells did, however, respond to N2A cell-conditioned medium 
with a very similar increase in NCAM transcript expression 
as did N2A cells themselves (Fig. 3, lanes c and d). Hence, 
the factor(s) released into the medium by N2A cultures also 
affect(s) NCAM expression by a different cell type. 
Modulation of NCAM Expression in NIH 313 Cells 
by TGF(3 
We  tested  a  variety  of pure  substances  known  to  affect 
growth and differentiation for their ability to restore NCAM 
protein levels in serum-starved N2A and 3T3 cells. The cells 
were cultured up  to  80%  conituency in  standard  growth 
medium, then switched to medium containing either low se- 
rum (0.2 or 0% for N2A and 3T3 cells, respectively) or 10% 
serum,  which was  supplemented with various agents.  We 
tested a variety of growth factors (PDGF, bFGF, EGF, insu- 
lin, and TGFB) and agents with effects on the state of  cellular 
activity or differentiation (retinoic acid and PMA). In N2A 
cells, none of these agents added for up to 48 h changed the 
steady-state levels of NCAM protein. In addition, NGF in 
concentrations from 2 to 8 nM was without effect on NCAM 
expression (data not shown). In serum-starved NIH 3T3 cells 
by contrast, TGF/~ restored the NCAM levels to those mea- 
sured in complete medium. All other agents tested had no 
or marginal effects (Table I). 
The response to TGFB was half-maximal at  18 pM,  in 
good agreement with a dissociation constant of 26 pM deter- 
mined for the interaction of TGFB with its receptor on 31"3 
cells (Massagu6 and Like,  1985) and reached a plateau at 
•100  pM (Fig.  5).  The stimulation of NCAM protein ex- 
pression by TGFB was not yet apparent after 8 h; after 15 h 
in the presence of  the agent, the increase in anti-NCAM anti- 
body binding averaged 94% over that measured in its absence 
(Fig. 6 A). TGF/~ was also capable of stimulating NCAM ex- 
pression in cultures grown in complete medium on top of  the 
increase elicited by serum alone. A similar increase in NCAM 
protein content in the presence of TGF/3 could also be dem- 
onstrated by immune blot analysis (Fig. 4, lanes 3 and 4). 
Since in this experiment the same number of cells from treated 
and untreated cultures was analyzed, TGF~ augments NCAM 
protein levels not only relative to total protein content but 
also on a per cell basis. 
In the experiments shown in Fig. 6, 3T3 cells in complete 
growth medium were switched to TGF~-containing medium 
with or without serum. Very similar results were obtained 
when quiescent cultures, serum-starved for 48 h, were stim- 
ulated with "I'GFt3  alone or with TGF/~ plus 10% FBS (Fig. 
7). In this type of experiment, TGF/~ increased NCAM pro- 
tein levels already after 8 h. Again, TGF/~ or 10% FBS alone 
stimulated NCAM protein expression to a very similar ex- 
Table L Effect of Various Agents on NCAM Protein Levels 
in 3T3 Cells 
Antibody bound 
Culture  condition  Exp.  1  Exp,  2  Exp.  3 
cpm/l~g protein 
10%  FBS  360  640  470 
0%  FBS  171  120  140 
0.3  nM PDGF  200  230  260 
20 nM EGF  210  150  180 
2  nM bFGF  154  ND  190 
100 nM insulin  230  ND  ND 
0.2  nM TGF/~  343  730  305 
20 nM PMA  ND  90  180 
20 nM retinoic acid  ND  130  170 
3T3 cells were grown up to 80% confluency and the medium replaced for 24 h 
with fresh  10%  FBS- or 0% FBS-containing medium supplemented or not in 
the latter case with the various agents at the concentration indicated.  Cell ly- 
sates were dot blotted and assayed for total NCAM immunoreactivity as de- 
scribed in the legend to Figure  1. 
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Figure 5. Dose response of  the TGF~ effect on NCAM protein levels 
in NIH 3T3 cells.  NIH 3T3 cells grown in 10% serum up to 80% 
confluency were  switched  to  serum-free  medium  supplemented 
with 0.1 to 200 pM TGF/L The cells were harvested  15 h later and 
the NCAM immunoreactivity measured by the dot-blot procedure. 
The results,  in cpm//~g protein, are expressed  as percent of maxi- 
mum stimulation  in the presence of 100  pM  TGFB.  The  100% 
value corresponds to 850 cpm/pg protein. 
tent, and the largest effect, a 3.8-fold stimulation of the con- 
trol value in serum-free medium after 24 h,  was produced 
by the combined action of serum and TGFB. 
The changes in NCAM protein content elicited by TGF/~ 
were  accompanied  by  changes  of  similar  magnitude  in 
NCAM mRNA levels. In the experiment shown in Fig. 8 B, 
treatment with 100 pM TGFB for 8 h produced an approxi- 
mate twofold increase  in the relative abundance of NCAM 
transcripts  in cells cultured in  10%  serum and an approxi- 
~gure 7. Stimulation of  NCAM 
protein abundance in quiescent 
NIH  3T3  cultures  by  "I'GF~ 
and serum factors.  Confluent 
3T3  cultures  made quiescent 
by serum starvation  for 48 h 
were switched to medium con- 
taining  10% FBS with (m) or 
without (i)  100 pM TGF/3 or 
to serum-free medium supple- 
mented  with  100  pM  TGF/3 
(B). The cells were harvested 
after 8 or 24 h and NCAM immunoreactivity determined by the dot 
blot procedure. The results,  in counts per minute/microgram pro- 
tein,  are the mean of determinations  done on two parallel  cultures 
(maximum variation between individual  values was +5 %) and are 
expressed  as fold stimulation  of control values  (225 cpm//~g pro- 
tein) from untreated  quiescent cultures.  The control value did not 
vary over the time period studied. 
mate  fourfold increase  in  serum-deprived  cells.  However, 
the  kinetics  of the  effects  on  protein  and  mRNA  levels 
differed. Stimulation of  mRNA expression was detectable al- 
ready after a 4  h  exposure to TGF/~,  peaked at around 8  h 
and was negligible after 24 h (Fig. 8 A). Together, serum fac- 
tors and TGF/3 were capable of modulating NCAM mRNA 
levels by a  factor of five, the lowest values being recorded 
in ceils  serum-starved for 15 h,  the highest ones after 8  h 
in the presence of serum and TGF/3 (Fig.  6 B). 
TGFB appeared neither to affect cell viability nor to stimu- 
late proliferation within the dose range and the times of ex- 
posure tested. This was confirmed by measuring the conver- 
sion of MTT to its formazan product (Mosmann,  1983) in 
parallel cultures. As shown in Fig. 6 C for a 15-h time point, 
formazin production was only slightly affected by the differ- 
ent  culture  conditions  making  it  unlikely  that  changes  in 
growth rate or metabolic state of the cells were responsible 
for the effects on NCAM expression. 
Figure 6.  Stimulation  of NCAM expression in NIH 3T3 cells  by TGFB.  3T3 cells  were grown in  10%  serum, then fresh  10%  serum- 
containing (g,  m) or serum free medium (m, n) without (L m) or with  (I, D)  100 pM TGFB was added and the cells  were harvested 
after 8 or 15 h as indicated.  (A) Quantification  of NCAM protein levels as measured by the dot blot procedure.  The results,  in counts 
per minute/microgram protein, are expressed  as fold stimulation  of the value measured in control cultures  with  10%  serum and without 
TGFB, which was 515  +  62 cpm/pg protein. (B) Quantification  of NCAM mRNA levels as measured by densitometric scanning of autora- 
diographs of Northern blots.  The results,  in relative  NCAM mRNA abundance after normalization relative  to GAPDH mRNA, are ex- 
pressed as fold stimulation  of the value measured in the control cultures with 10% serum and without TGF~. In A and B, the results are 
expressed as the mean +  SEM (indicated by the bar) for the number of independent  experiments  given above. (C) Sister cultures maintained 
for 15 h in the various conditions were treated with MTT and the formazin production determined by measuring the absorbance at 540 nm 
as an indication  of metabolic activity and cell  density. 
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NCAM Expression 
Relative levels of NCAM  mRNA 
Culture  condition  -  Actinomycin D  +  Actinomycin  D 
10%  FBS  0.11  +  0.05  0.09  +  0.04 
10%  FBS  +  100 pM TGF/~  0.21  +  0.09  0.08  +  0.02 
3T3 cells were grown to 80% confluency in 10% FBS. Then, new medium was 
added with or without 100 pM TGFB and 2.5 #g/ml actinomycin D. The cells 
were harvested 6 h later.  Results are the mean  +  SD of three  experiments. 
Figure 8. Time course of TGF~-induced changes in NCAM mRNA 
abundance. (A) NIH 3T3 cells were cultured for various time inter- 
vals in 10% FBS-containing (o) or serum-free (o) medium with or 
without 100 pM TGF/L Northern blots of total RNA were hybrid- 
ized with NCAM and GAPDH probes. The autoradiographs  were 
scanned and the densitometric  values given by the 6.1-kb NCAM 
mRNA band normalized  relative to the intensity  of the GAPDH 
band revealed on the same blot.  The results are expressed as the 
percentage  of the maximum stimulation  obtained  after 8 h.  The 
mean value from three  independent experiments  is given; the in- 
dividual values differed by <+5%.  (B) The autoradiograph  of a 
typical Northern blot is presented for the 8-h time point. The crude 
and  normalized  values  of the  densitometric  scanning  are given 
below. 
The Effect of TGF/3 on NCAM Expression Is Exerted at 
Least in Part at the Transcriptional Level 
As a first step towards characterizing the mechanism whereby 
TGF/3 increases NCAM mRNA levels, we sought to deter- 
mine if transcription was required for the effect to occur and 
whether the stimulation of NCAM mRNA accumulation re- 
sulted from increased transcription of the gene or from in- 
creased stabilization of the mRNA. As shown in Table II, ac- 
tinomycin D added together with TGF/3 completely abrogated 
the response measured 6 h later without affecting the relative 
abundance of NCAM transcripts  in  the absence of TGF/~ 
Over this time period and at the dose used, actinomycin D 
did not appear to have any detrimental effect on cell viability 
(data not shown). Hence, the response to TGF/3 requires the 
synthesis of new mRNA, either of transcripts that code for 
proteins which are intermediates in the chain of events lead- 
ing to the increases in NCAM mRNAI or of NCAM mRNA 
itself (or both). We then measured the decay of NCAM mRNA 
in actinomycin D-treated cells in the presence and absence 
of TGF/3. Cultures in complete and serum-free medium were 
pretreated for 8 h  with 100 pM TGF/3 or not. Then, actin- 
omycin D (5 #g/ml) was added to block transcription and the 
NCAM mRNA content determined by a dot-blot procedure. 
As shown in Fig.  9,  NCAM mRNA levels declined with a 
very similar time course whether TGF/3 was present or not. 
As a control, the GAPDH mRNA content was measured in 
the same blots after stripping of the NCAM probe; in accord 
with previous studies (Dani et al.,  1984), the GAPDH tran- 
scripts decayed with a half-life of '~8 h.  We thus conclude 
that the increase in NCAM mRNA elicited by TGF/3 does not 
result from stabilization of the message implying that the 
agent increases the transcriptional activity of the NCAM gene. 
We turned to transfection assays using recombinant plas- 
raids containing a previously identified transcriptional con- 
trol region (Hirsch et al., 1990) from the 5' end of the NCAM 
gene coupled to the CAT gene as indicator gene to demon- 
strate that  TGFfl was  indeed  capable of stimulating  tran- 
scription from the  NCAM gene promoter.  The constructs 
were transfected into 3T3 cells that were then either main- 
tained in 10% FBS or shifted to low serum with or without 
200 pM "I'GF/3 and processed for determination of CAT ac- 
tivity 40 to 48 h  later. A  typical example is shown in Fig. 
10. In three independent experiments, TGF/3 stimulated CAT 
activity 1.95  +  0.35- and 1.63 +  0.09- (mean +  SEM) fold 
in the presence of low and high serum,  respectively. The 
CAT expression directed by the NCAM promoter was also 
stimulated by serum, 2.90 +  0.10 times as much enzyme ac- 
tivity being expressed in the presence than in the absence of 
10%  FBS.  The combined action of serum and TGF/~ pro- 
duced a near fivefold change in CAT activity. The increases 
Roubin et  al. Modulation  of  NCAM Expression  679 A 
100  ~)~  NC~  100 
80.  80, 
i  40"  40. 
i 
<  20 .|  10% NBS+TGFp  20 '  i, 
1  0  -  '  0 
0  6  12 
tlmo (h) 
B 
NCAIA 
O% NBS+_TGF J3 
tlmm (h) 
c 
6O 
!  ,o 
o  ;  ,'2 
tim(h) 
D 
+_ 
lira i~) 
Figure 9. Effect of TGF/3 on NCAM transcript stability in NIH 3T3 cultures. NIH 3T3 cells were cultured up to 80% confluency in 10% 
serum. Then, the cells were switched to 10% serum-containing (A and C) or serum-free (B and D) medium supplemented with 100 pM 
TGF~ (e) or not (o). 8 h later, 5 t~g/mt actinomycin D was added and the cells harvested after the time intervals indicated.  RNA was 
extracted and NCAM mRNA levels determined by dot-blot hybridization. As a control, the same blots were rehybridized with the GAPDH 
probe after stripping of the NCAM probe. The decay of NCAM and GAPDH mRNA levels was plotted as the percentage of specific mRNA 
remaining at the different times relative to the zero time sample, which was set at 100%. 
in promoter activity elicited by TGFfl or serum were thus 
very similar to the magnitude of their effects on the steady- 
state levels of the mRNA suggesting that most if not all of 
the response to TGF/3 and serum factors can be attributed 
to increased transcriptional activity of the NCAM gene. 
TGF[3 Increases NCAM Protein and mRNA in Early 
Passage Embryo Cells 
We used  first- and  second-passage embryo cells prepared 
from  16-d-old mouse embryos as  a  first approach to test 
whether the TGFfl effect could also be observed in cells, 
which can be considered as reflecting more closely the situa- 
tion in the embryo than the 3T3 line. When analyzed by im- 
mune blotting,  first passage embryo ceils expressed easily 
detectable levels of the 140-kD form of NCAM, which were 
increased by exposure to TGFfl (Fig. 4, lanes 5 and 6). An 
increase in NCAM protein levels was first seen after 24 h in 
the presence of the agent; after 48 h, an over fourfold stimu- 
lation of NCAM protein content was observed (Fig.  11 A). 
In Northern blots, the embryo-derived cultures were found 
to express mainly the 6.1-kb RNA with smaller amounts of 
the two transcripts of 2.7 and 4.8 kb that code for NCAM-120 
(Fig.  11 B). Treatment with TGF/3 produced an increase in 
the steady-state levels of the 6.1-kb  message, whereas this 
effect was less obvious for the smaller transcripts. The results 
from several experiments of this type were quantified by den- 
sitometry and expressed relative to the GAPDH levels. A 
near twofold increase in the relative abundance of the 6.1-kb 
band was recorded after an 8-h exposure, somewhat less af- 
ter 48  h.  Clearly,  early passage embryo cells respond to 
TGF/3 with  very similar increases  in  NCAM protein  and 
mRNA as do 3T3 cells. 
Discussion 
To fulfill its supposed role as a morphoregulatory molecule 
(Edelman, 1985;  1988), NCAM must not only regulate, but 
also  be  regulated  by  cellular  interactions.  However,  the 
mechanisms and in particular the  extracellular factors in- 
volved in the control of NCAM expression have remained 
largely unknown. Thus far, the only published examples of 
defined,  naturally occurring factors that affect NCAM ex- 
pression are NGF and laminin.  NGF has been reported to 
upregulate NCAM in PC12 cells concomitant with a shift in 
the relative proportion of NCAM isoforms (Prentice et al., 
1987;  Doherty et al.,  1988).  Still, control of NCAM levels 
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in 3T3 cells. The cells were transfected with 20 #g of  a recombinant 
plasmid  in which CAT gene expression is controlled by the  se- 
quence between positions  -645 to -37 (relative to the initiation 
methionine) of the NCAM promoter (Hirsch et al.,  1990). After 
transfection, the cells were pooled and redistributed into four flasks, 
one for each condition: medium containing 0.2 or 10% FBS and 
supplemented with 200 pM TGF/$ (+) or not (-). The cells were 
harvested 40-48 h after transfection and CAT activity determined 
on aliquots containing equal amounts of protein.  The autoradio- 
graph of a thin layer plate is shown; below is given the percent con- 
version  into  acetylated  [~4C]chloramphenicol derivatives.  As  a 
control,  sister cultures were transfected with RSVCAT (Gorman, 
1985); the CAT activity directed by this plasmid was not affected 
by TGF~ (not shown). 
by NGF does not seem to be a general phenomenon; NGF 
had no effect on NCAM expression by PC12 cells in another 
study  (Friedlander  et  al.,  1986)  and  did  also  not  affect 
NCAM levels in Schwann cells (Seilheimer and Schachner, 
1987), although the adhesion molecule L1 was upregulated 
in both cell types. Laminin, when used as culture substrate, 
has been shown to change NCAM  isoform expression by 
N2A cells (Pollerberg et al.,  1986); however, the absolute 
levels of the NCAM forms have not been measured in this 
work. In this study, we have used two permanent cell lines 
to search for factors capable of modulating NCAM expres- 
sion. In N2A and NIH 3T3 cells, NCAM expression was up- 
regulated by serum and by a factor contained in N2A cell- 
conditioned medium.  TGF/~ was found to increase NCAM 
protein and mRNA levels in 3T3 and in early-passage fibro- 
blastic cells from mouse embryos. 
Serum increased the steady-state levels of NCAM protein 
and mRNA in N2A and 3T3 ceils compared with total protein 
content and with the levels of GAPDH mRNA used as refer- 
ence. The expression of the L1 adhesion molecule, by con- 
trast, decreased in N2A cells grown in high serum, provid- 
ing further evidence for the selective nature of the serum 
response. The increase in total NCAM message after addi- 
tion of serum to serum-starved N2A cells can be entirely ac- 
counted for by increased levels of the 6.1-kb  species that 
codes for NCAM-140 (Barbas et al., 1988). Since the differ- 
ent transcripts arise from a single gene by alternative splicing 
(Cunningham et al., 1987; Barbas et al., 1988), serum could 
act either by selectively increasing the stability of the 6.1-kb 
transcript, thus affecting both the ratio between the two mRNA 
species and the amount of total NCAM message, or by chang- 
ing transcriptional activity and the mode of splicing via inde- 
pendent mechanisms. We favor the second possibility since 
serum factors are capable of stimulating NCAM promoter 
activity in 3T3 cells and since preliminary results suggest 
that this is also true for N2A cells. 
The strong dependence of NCAM expression on cell den- 
sity in N2A cultures suggested that the regulation of NCAM 
levels in these cells might also involve an autocrine mecha- 
nism.  Indeed, exposure to medium conditioned over N2A 
cells resulted in increased steady-state levels of NCAM tran- 
scripts in both N2A and  3T3 cells.  Previous studies have 
provided evidence that N2A cells produce and are responsive 
to PDGF (Van Zoelen et al.,  1985). In our hands, however, 
PDGF was without effect  on NCAM expression by N2A ceils 
as were the other growth and differentiation factors tested. 
In any case, the putative autocrine factor cannot be TGFfl, 
which had no effect on N2A cells, and must be distinct from 
the serum factor, since it increased both the 6.9- and the 6.1- 
kb transcripts. 
A major finding that emerges from our study is that TGF/3 
stimulated NCAM expression by 3T3 and normal mouse em- 
bryo cells at both the mRNA and protein levels. In 3T3 cells, 
where this has been investigated, the TGF/3 effect required 
de novo mRNA synthesis and did not appear to be due to 
changes  in  mRNA  stability.  The obvious implication that 
TGF/~ stimulates transcription is strongly supported by the 
finding that the factor increased the activity of the NCAM 
promoter in transfection assays.  As shown recently (Rossi et 
al.,  1988), TGF/3 activates transcription from the collagen 
type I promoter, an effect mediated by a nuclear factor I-bind- 
ing site. Interestingly, the NCAM promoter fragment used 
contains also a site to which this factor binds (Hirsch et al., 
1990). We are currently investigating whether nuclear factor 
I is involved in the stimulation of the NCAM promoter by 
TGF/~. 
TGF/~ was the only defined factor tested that restored the 
reduced NCAM content of serum-starved 3T3 cultures. In 
spite of this, the serum stimulation of NCAM expression is 
probably not due to TGF/$, which might have been present 
in the serum,  since the increases in NCAM mRNA abun- 
dance elicited by optimum doses of the factor were very 
similar whether serum was present or not. The two- to three- 
fold increase in the levels of NCAM protein (over fourfold 
in the embryo cells) we observed with optimum doses of 
TGF/$ may seem modest. However, comparable changes in 
NCAM concentration have been reported to result in large 
effects on adhesion (Hoffman and Edelman,  1983) and on 
neurite outgrowth (Doherty et al.,  1990), and an only two- 
fold modulation in cell surface expression of NCAM may 
have important functional consequences. 
Because of its stimulating effect on matrix deposition and 
stability and on the expression of the corresponding cellular 
receptors, TGF/~ is supposed to increase the adhesive inter- 
Roubin ¢t al. Modulation of NCAM Expression  681 Figure 11. Effect of TGF8 on NCAM protein and mRNA abundance in first- and second-passage embryo-derived cells. (A) Time course 
of the changes in NCAM protein (o) and mRNA (x) levels. The ceils were cultured for the time intervals indicated in the presence of 
200 pM TGFB. Control values in the absence of the agent did not vary over the time period considered.  Protein levels were determined 
by scanning suitable exposures of immune blots like the one shown in Fig. 4; the results, in arbitrary units, were corrected with respect 
to total protein loaded on each lane and expressed as fold stimulation of the value measured in the absence of TGF/$. Autoradiographs 
of Northern blots like the one shown in Fig.  11 B were scanned and the densitometric  values given by the 6.1-kb RNA band normalized 
relative to the intensity of the GAPDH band; the values are expressed as fold stimulation of the value measured in the absence of the agent. 
Except for the 48-h time point, where only two experiments have been performed and the mean value is given, the values shown are the 
mean +  SEM for three independent experiments. B shows a typical Northern blot for first passage cells. In addition to the major 6.l-kb 
species, minor bands at 4.8 and 2.7 kb are also revealed. 
actions  between  cells  and  their  extracellular environment 
(Ignotz and Massagu6,  1987;  Edwards et al.,  1987;  Ignotz 
et al.,  1987;  Heino et al.,  1989). The stimulation of NCAM 
expression we observe implies that the same factor may also 
enhance adhesion between cells. Since the effect on NCAM 
seems to be less lasting than the one on matrix deposition, 
one may speculate that increased cell-cell adhesion is an ini- 
tial response to TGFB, to be supplanted later by enhanced 
interaction with extracellular substrates.  However, the dis- 
tinction between cell-cell and cell-matrix adhesion mole- 
cules is not always sharp, and NCAM may mediate cell-ma- 
trix adhesion  via its interaction with heparin and heparan 
sulfate (Cole and Akeson,  1989)  in addition  to promoting 
adhesion between cells. 
The striking association of TGFB with morphogenetically 
active regions  and  with  the  mesenchyme in  areas of em- 
bryonic induction has led to the suggestion that TGF/$ partic- 
ipates in shaping the basic organization and architecture of 
the embryo (Heine et al.,  1987;  Akhurst et al.,  1989).  Our 
results suggest that TGF/$ may do this in part by promoting 
the expression of NCAM.  TGFB2 but not TGFB~ has been 
shown  to  have mesoderm-inducing  activity  in  amphibian 
embryos (Rosa et al.,  1988).  In our hands,  pure/3t and 152 
types  of  TGF  were  about  equally  active  in  stimulating 
NCAM expression by 3T3 cells (results not shown), although 
we have done detailed dose-response and kinetic studies only 
with  human  platelet-derived  TGFB  which  should  consist 
only of TGFB, (Cheifetz et al.,  1987). 
Cellular and molecular mechanisms involved in embryo- 
genesis may be reiterated during tissue repair in the adult. 
Indeed, a common theme underlying some of the diverse ac- 
tions of TGF~ appears to be its function as a stimulator of 
repair and regeneration in response to injury (Sporn et al., 
1987;  Pierce et al.,  1989; Rizzino,  1988).  NCAM has been 
implicated  in  processes  of regeneration  in  the  peripheral 
nerve and the denervated muscle.  Transecting or crushing 
the  sciatic  nerve stimulates  NCAM  protein expression  in 
Schwann cells and fibroblasts as determined by immunocy- 
tology (Daniloff et al.,  1980; Martini and Schachner,  1988) 
and denervation induces NCAM expression on the muscle 
fibers (Covault and Sanes, 1985; Rieger et al.,  1985) and on 
interstitial  fibroblasts  (Gatchalian  et  al.,  1989).  These 
fibroblasts not only accumulate NCAM, but also fibronectin 
and tenascin, both of which have been shown to increase af- 
ter exposure to TGFB in other systems (Ignotz et al.,  1987; 
Adams Pearson et al., 1988). TGFB may thus function as one 
of the signals that mediate local stimulation of NCAM ex- 
pression in rrluscle and nerve after injury. 
The Journal of Cell Biology, Volume 111,  1990  682 Although  we have  no  direct proof that  TGFB  regulates 
NCAM expression in vivo, our results obtained with early- 
passage embryo cells strongly suggest that this factor partici- 
pates  in the  control of NCAM  expression in the embryo. 
TGFB is certainly not the only factor involved in the regula- 
tion of NCAM expression as already  indicated by the stim- 
ulatory effect of factors contained in serum and secreted by 
N2A cells. The identification of the extracellular signals that 
regulate NCAM levels in different  cell types wiU be an im- 
portant  step towards unravelling the mechanisms by which 
cell-cell adhesion is regulated. Our evidence indicates that 
serum factors and TGF/~ stimulate transcription  from the 
NCAM promoter.  It will now be possible to investigate  the 
nuclear factors and their targets that are involved in this regu- 
lation. 
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